194 related articles for article (PubMed ID: 17525794)
41. MNAR plays an important role in ERa activation of Src/MAPK and PI3K/Akt signaling pathways.
Cheskis BJ; Greger J; Cooch N; McNally C; Mclarney S; Lam HS; Rutledge S; Mekonnen B; Hauze D; Nagpal S; Freedman LP
Steroids; 2008 Oct; 73(9-10):901-5. PubMed ID: 18261753
[TBL] [Abstract][Full Text] [Related]
42. Characterization of the interactions of estrogen receptor and MNAR in the activation of cSrc.
Barletta F; Wong CW; McNally C; Komm BS; Katzenellenbogen B; Cheskis BJ
Mol Endocrinol; 2004 May; 18(5):1096-108. PubMed ID: 14963108
[TBL] [Abstract][Full Text] [Related]
43. The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer.
Aust S; Horak P; Pils D; Pils S; Grimm C; Horvat R; Tong D; Schmid B; Speiser P; Reinthaller A; Polterauer S
BMC Cancer; 2013 Mar; 13():115. PubMed ID: 23497172
[TBL] [Abstract][Full Text] [Related]
44. A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer.
Altwegg KA; Viswanadhapalli S; Mann M; Chakravarty D; Krishnan S; Liu Z; Liu J; Pratap UP; Ebrahimi B; Sanchez JR; Li X; Ma S; Park BH; Santhamma B; Chen Y; Lai Z; Raj GV; Yuan Y; Zhou D; Sareddy GR; Tekmal RR; McHardy S; Huang TH; Rao MK; Vankayalapati H; Vadlamudi RK
Cancer Res; 2022 Oct; 82(20):3830-3844. PubMed ID: 35950923
[TBL] [Abstract][Full Text] [Related]
45. The pattern of proline, glutamic acid, and leucine-rich protein 1 expression in Chinese women with primary breast cancer.
Zhang Y; Wang P; Shi M; Sasano H; Chan MS; Dai J; Guo L; Liu M; Wang X; Ma Y; Wang L
Int J Biol Markers; 2014 Mar; 29(1):e1-7. PubMed ID: 24627205
[TBL] [Abstract][Full Text] [Related]
46. Proline, glutamic acid and leucine-rich protein-1 is essential for optimal p53-mediated DNA damage response.
Nair BC; Krishnan SR; Sareddy GR; Mann M; Xu B; Natarajan M; Hasty P; Brann D; Tekmal RR; Vadlamudi RK
Cell Death Differ; 2014 Sep; 21(9):1409-18. PubMed ID: 24786831
[TBL] [Abstract][Full Text] [Related]
47. Inflammation-induced PELP1 expression promotes tumorigenesis by activating GM-CSF paracrine secretion in the tumor microenvironment.
Vuttaradhi VK; Ezhil I; Ramani D; Kanumuri R; Raghavan S; Balasubramanian V; Saravanan R; Kanakarajan A; Joseph LD; Pitani RS; Sundaram S; Sjolander A; Venkatraman G; Rayala SK
J Biol Chem; 2022 Jan; 298(1):101406. PubMed ID: 34774800
[TBL] [Abstract][Full Text] [Related]
48. Delivery of cytoplasmic proteins to autophagosomes.
Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
Autophagy; 2008 Jan; 4(1):104-6. PubMed ID: 18000392
[TBL] [Abstract][Full Text] [Related]
49. Expression of estrogen receptor co-regulators NCoR and PELP1 in epithelial cells and myofibroblasts of colorectal carcinomas: cytoplasmic translocation of NCoR in epithelial cells correlates with better [corrected] prognosis.
Tzelepi V; Grivas P; Kefalopoulou Z; Kalofonos H; Varakis JN; Sotiropoulou-Bonikou G
Virchows Arch; 2009 Jan; 454(1):41-53. PubMed ID: 19048289
[TBL] [Abstract][Full Text] [Related]
50. Altered Expression of
Englert-Golon M; Andrusiewicz M; Żbikowska A; Chmielewska M; Sajdak S; Kotwicka M
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207568
[TBL] [Abstract][Full Text] [Related]
51. The histone variant MacroH2A1 regulates target gene expression in part by recruiting the transcriptional coregulator PELP1.
Hussey KM; Chen H; Yang C; Park E; Hah N; Erdjument-Bromage H; Tempst P; Gamble MJ; Kraus WL
Mol Cell Biol; 2014 Jul; 34(13):2437-49. PubMed ID: 24752897
[TBL] [Abstract][Full Text] [Related]
52. Cryo-EM reveals the architecture of the PELP1-WDR18 molecular scaffold.
Gordon J; Chapus FL; Viverette EG; Williams JG; Deterding LJ; Krahn JM; Borgnia MJ; Rodriguez J; Warren AJ; Stanley RE
Nat Commun; 2022 Nov; 13(1):6783. PubMed ID: 36351913
[TBL] [Abstract][Full Text] [Related]
53. Increased expression of proline-, glutamic acid- and leucine-rich protein PELP1 in non-small cell lung cancer.
Słowikowski BK; Gałęcki B; Dyszkiewicz W; Jagodziński PP
Biomed Pharmacother; 2015 Jul; 73():97-101. PubMed ID: 26211588
[TBL] [Abstract][Full Text] [Related]
54. Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin.
Manavathi B; Kumar R
J Cell Physiol; 2006 Jun; 207(3):594-604. PubMed ID: 16270355
[TBL] [Abstract][Full Text] [Related]
55. [PELP1/MNAR: a newly discovered nuclear receptor co-regulator].
Wang L; Zhao L; Sun HL
Sheng Li Ke Xue Jin Zhan; 2010 Jun; 41(3):225-8. PubMed ID: 21416987
[No Abstract] [Full Text] [Related]
56. Scaffolding proteins mediating membrane-initiated extra-nuclear actions of estrogen receptor.
Boonyaratanakornkit V
Steroids; 2011 Aug; 76(9):877-84. PubMed ID: 21354435
[TBL] [Abstract][Full Text] [Related]
57. PELP1 suppression inhibits colorectal cancer through c-Src downregulation.
Ning Z; Zhang Y; Chen H; Wu J; Song T; Wu Q; Liu F
Oxid Med Cell Longev; 2014; 2014():193523. PubMed ID: 24967003
[TBL] [Abstract][Full Text] [Related]
58. Phosphorylation of MNAR promotes estrogen activation of phosphatidylinositol 3-kinase.
Greger JG; Fursov N; Cooch N; McLarney S; Freedman LP; Edwards DP; Cheskis BJ
Mol Cell Biol; 2007 Mar; 27(5):1904-13. PubMed ID: 17194752
[TBL] [Abstract][Full Text] [Related]
59. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
60. Significantly increased PELP1 protein expression in primary and metastatic triple-negative breast carcinoma: comparison with GATA3 expression and PELP1's potential role in triple-negative breast carcinoma.
Dang DN; Raj G; Sarode V; Molberg KH; Vadlamudi RK; Peng Y
Hum Pathol; 2015 Dec; 46(12):1829-35. PubMed ID: 26428280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
